Jasveen Sangha, the individual dubbed the “Ketamine Queen” by federal prosecutors, has recently made headlines in connection to the tragic death of actor Matthew Perry. Perry was found deceased in his home in Los Angeles on October 28, 2023, and an autopsy revealed that his passing was attributed to a combination of ketamine, drowning, coronary artery disease, and effects from medication used to treat opioid use disorder. This discovery led to a wave of investigations that ultimately implicated Sangha in the distribution of ketamine that resulted in Perry’s demise.
:max_bytes(150000):strip_icc():format(jpeg)/jasveen-sangha-matthew-perry-main-081925-ac33d11f6d7b4c5eae80dd7f350a2261.jpg)

After nearly two years since Perry’s death, Jasveen Sangha reached a significant development in her case by agreeing to a plea deal in connection to the charges related to Perry’s passing. Prosecutors announced in August 2025 that Sangha would plead guilty to distribution of ketamine, maintaining a drug-involved premises and distribution of ketamine resulting in death or serious bodily injury. This decision marks a crucial step in the legal proceedings surrounding Perry’s tragic loss, with Sangha being one of five defendants implicated in the case.

Hailing from the U.S. and the U.K., Sangha has been described as a former drug dealer who gained notoriety for her involvement in the distribution of narcotics, particularly ketamine. Prior to her arrest in August 2024, she portrayed herself online as a curator of art and events, showcasing a glamorous lifestyle that mingled with the celebrity circuit. However, authorities alleged that behind this façade, Sangha operated a stash house in North Hollywood where she managed the storage, packaging, and distribution of illicit substances.
The intricate web linking Jasveen Sangha to Matthew Perry’s untimely passing involves intermediary figures, such as Erik Fleming and Kenneth Iwamasa. Prosecutors stated that Sangha supplied drugs to Fleming, who then passed them along to Perry’s assistant, Iwamasa. Tragically, Perry was injected with ketamine by Iwamasa, leading to his fatal overdose. The allegations suggest a chain of events orchestrated by Sangha that culminated in the distribution of the substance that claimed Perry’s life.
In response to the mounting evidence against her, Sangha’s legal strategy pivoted as she transitioned from pleading not guilty to agreeing to a guilty plea in August 2025. The plea agreement entails charges related to maintaining a drug-involved premises, distribution of ketamine, and distribution of ketamine resulting in death or serious bodily injury. Given the severity of these charges, Sangha faces the prospect of a lengthy prison sentence should the court rule in favour of the prosecution.
Throughout the unfolding legal proceedings, United States Attorney Martin Estrada emphasised the grave consequences of drug-related crimes, highlighting the exploitation of vulnerable individuals struggling with addiction. The case surrounding Jasveen Sangha and her involvement in Matthew Perry’s passing serves as a stark reminder of the dangers posed by illicit drug distribution networks and the devastating impact they can have on individuals and communities.
As the narrative of Jasveen Sangha, the so-called “Ketamine Queen,” continues to evolve in the criminal justice system, the repercussions of her actions reverberate across both legal and societal dimensions. The intricacies of this case underscore the complexities of drug-related crimes and the imperative need for accountability in combating illicit substance distribution networks.
